Context Therapeutics Inc.

SEC 4 · Filed

0001628280-26-045778Accepted

Applies to the EDGAR acceptance time.

Other time zone
Insider transactionsEvent date Jun 24, 2026

Grant, award or other acquisition by Smith Karen L.

Security
Stock Option (right to buy)
Code
A
Shares
45,000
Price per share
0.00
Structured facts
{
  "code": "A",
  "date": "2026-06-24",
  "direction": "A",
  "exercise_price": "0.576",
  "expiration": "2036-06-23",
  "footnotes": {
    "F1": "The option vests and becomes exercisable on the earlier of (i) June 24, 2027 (the one-year anniversary of the date of grant) or (ii) the Issuer\u0027s 2027 annual meeting of stockholders, subject to continued service with the Issuer."
  },
  "owners": [
    {
      "cik": "0001639637",
      "name": "Smith Karen L.",
      "roles": [
        "director"
      ],
      "title": null
    }
  ],
  "ownership": "D",
  "post_shares": "45000",
  "price": "0",
  "row": 1,
  "rule_10b5_1": "0",
  "security": "Stock Option (right to buy)",
  "shares": "45000",
  "table": "II",
  "underlying_security": "Common Stock",
  "underlying_shares": "45000"
}